The activation of NLRP3 inflammasome has been demonstrated to contribute to pathology in a broad spectrum of neurological diseases, such as traumatic brain injury, spinal cord injury, Alzheimer’s disease, amyotrophic lateral sclerosis, and MS [35]. This evidence concerns the gene NLRP3 and early-onset autosomal dominant Alzheimer disease.